Molecular characterization of familial hypercholesterolemia in German and Greek patients

✍ Scribed by George V. Z. Dedoussis; Janine Genschel; Bettina Bochow; Christos Pitsavos; John Skoumas; Margarita Prassa; Sodnomtsogt Lkhagvasuren; Pavlos Toutouzas; Anja Vogt; Ursula Kassner; Hans-P. Thomas; Hartmut Schmidt

• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 42 KB
• Volume: 23
• Category: Article
• ISSN: 1059-7794
• DOI: 10.1002/humu.9218

✦ Synopsis

We used the denaturing gradient gel electrophoresis (DGGE) method to define mutations in the promoter region, the 18 exons, and their flanking intronic sequences of the low-density lipoprotein (LDL) receptor gene LDLR, causing familial hypercholesterolemia (FH) phenotype in 100 German and in 100 Greek hypercholesterolemic individuals. In addition, we tested all patients for the presence of mutations in codons 3456-3553 of the gene encoding apolipoprotein B-100 (APOB). Twenty-six aberrant DGGE patterns were identified and subsequently directly sequenced. In LDLR, two novel missense mutations (c.1957G>T/p.V653F, c.647 G>A/p.C216Y) and one novel homozygous base substitution c.1-156 C>T in the repeat 2 of the promoter region were identified among German FH patients; one novel splice site c.1060+10C>G was identified among Greek FH patients. One of the German FH patients was a carrier for the mutations c.1171G>A/p.A391T and p.V653F, and two of the Greek FH patients were compound heterozygotes for the mutations c.1150C>T/p.Q384X and c.1158C>G/p.D386E. Two German FH patients carried the mutation p.R3500Q within APOB. Comparing the mutations within the LDLR gene of the two European FH populations, the German population seems to be more heterogeneous than the Greek cohort. Further studies in progress are trying to elucidate the responsiveness to drug therapy in association with LDLR genotype and the nutritional habits of the two FH populations.